SCHEMBL3663635

SCHEMBL3663635

Cc1ccc(/C=C(\CCl)c2ccc(Cl)cc2F)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.38
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
CXCL12 P48061 1/20 0.38
LMNA P02545 3/20 0.36
PTGS1 P23219 1/20 0.35
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MAPK1 P28482 1/20 0.34
HIF1A Q16665 1/20 0.34
TP53 P04637 1/20 0.34
MEN1 O00255 2/20 0.33
MAPT P10636 2/20 0.33
KMT2A Q03164 2/20 0.33
SLC6A4 P31645 1/20 0.33
KDM4E B2RXH2 1/20 0.33
PLA2G1B P04054 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3768738 1.00 NFE2L2 (0.38) NFE2L2MAOAMAOBNPSR1CXCL12
SCHEMBL3777736 0.91 PTGS1 (0.39) NFE2L2MAOAMAOBCXCL12PTGS1
SCHEMBL3665474 0.91 PTGS1 (0.39) NFE2L2MAOAMAOBCXCL12PTGS1
SCHEMBL3770118 0.87 NFE2L2 (0.45) NFE2L2NPSR1LMNAPTGS1MEN1
SCHEMBL3770122 0.87 NFE2L2 (0.45) NFE2L2NPSR1LMNAPTGS1MEN1
SCHEMBL3124317 0.82 MAOB (0.43) MAOBNPSR1LMNAPTGS1CYP11B1
SCHEMBL3124324 0.82 MAOB (0.43) MAOBNPSR1LMNAPTGS1CYP11B1
SCHEMBL3772088 0.81 FBP1 (0.40) MAOBCXCL12LMNAPTGS1CYP11B2
SCHEMBL3663676 0.81 FBP1 (0.40) MAOBCXCL12LMNAPTGS1CYP11B2
SCHEMBL3661934 0.75 NFE2L2 (0.41) NFE2L2LMNACYP11B1CYP11B2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100317515-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same BASF SE (DE) 2010-12-16 US disclosed
EP-2234488-A2 AZOLYLMETHYLOXIRANES, USE THEREOF AND AGENTS CONTAINING THE SAME BASF SE (DE) 2010-10-06 EP disclosed
WO-2009077443-A2 AZOLYLMETHYLOXIRANES, USE THEREOF AND AGENTS CONTAINING THE SAME BASF SE (DE) 2009-06-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100317515-A1 Azolylmethyloxiranes, use Thereof and Agents Containing the Same XDH, NOX5, TET1 NFE2L2 825/4885MAOA 79/4885MAOB 53/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.